Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target 8%
FROM THE WIRE · ECONOMICTIMES.INDIATIMES.COM
Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishThe raised annual guidance and higher broker targets support the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Shares hit the 10% upper circuit after strong Q2 FY27 results.
- 02The company raised its full-year growth guidance.
- 03Brokerages cited robust international business and a strong product pipeline.